Texas - Natera, Inc. , a global leader in cell-free DNA testing, today announced a new study published in Gynecologic Oncology validating its personalized and tumor-informed molecular residual...

Related Keywords

San Carlos , California , United States , Texas , Lesley Bogdanow , Mike Brophy , Clinical Laboratory Improvement Amendments , Natera Inc , Nasdaq , Gynecologic Oncology , News Publishing , Markets ,